Sex hormone-binding globulin gene expression and insulin resistance

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 12, 2014, Pages E2780-E2788

  Winters, Stephen J ^a   Gogineni, Jyothi ^a   Karegar, Marjan ^a   Scoggins, Charles ^a   Wunderlich, Chris A ^b   Baumgartner, Richard ^b   Ghooray, Dushan T ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MESSENGER RNA; SEX HORMONE BINDING GLOBULIN; TRIACYLGLYCEROL; HEPATOCYTE NUCLEAR FACTOR 4; HNF4A PROTEIN, HUMAN;

ADULT; AGE; ARTICLE; BODY MASS; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GLOBULIN BLOOD LEVEL; HNF4ALPHA GENE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIPID STORAGE; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SHBG GENE; TRANSCRIPTION REGULATION; AGED; FATTY LIVER; GENETICS; LIVER; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; GENE EXPRESSION; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; INSULIN RESISTANCE; LIVER; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SEX HORMONE-BINDING GLOBULIN;

EID: 84916604860     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2640     Document Type: Article

References (69)

1. Hammond GL, Bocchinfuso WP. Sex hormone-binding globulin: Gene organization and structure/function analyses. Horm Res. 1996;45-197-201.
2. Joseph DR. Structure, function, and regulation of androgen-binding protein/sex hormone-binding globulin. Vitam Horm. 1994;49-197-280.
3. Rosner W, Hryb DJ, Khan MS, Nakhla AM, Romas NA. Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane. J Steroid Biochem Mol Biol. 1999;69:481-485.
4. Hammes A, Andreassen TK, Spoelgen R, et al. Role of endocytosis in cellular uptake of sex steroids. Cell. 2005;122:751-762.
5. Jayagopal V, Kilpatrick ES, Jennings PE, Hepburn DA, Atkin SL. The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: Implications for SHBG as a surrogate marker of insulin resistance. J Clin Endocrin Metab. 2003;88:1528-1533.
6. Sørensen K, Andersson AM, Skakkebaek NE, Juul A. Serum Sex Hormone-Binding Globulin Levels in Healthy Children and Girls with Precocious Puberty before and during Gonadotropin-Releasing Hormone Agonist Treatment. J Clin Endocrinol Metab. 2007;92:3189-3196.
7. Anderson DC. Sex-hormone-binding globulin. Clin Endocrinol. 1974;3:69-96.
8. Vanbillemont G, Lapauw B, De Naeyer H, Roef G, Kaufman JM, Taes YE. Sex hormone-binding globulin at the crossroad of body composition, somatotropic axis and insulin/glucose homeostasis in young healthy men. Clin Endocrinol. 2012;76(1):111-118.
9. Glass AR, Swerdloff RS, Bray GA, Dahms WT, Atkinson RL. Low serum testosterone and sex-hormone-binding-globulin in massively obese men. J Clin Endocrinol Metab. 1977;45:1211-1219.
10. Guzick DS, Wing R, Smith D, Berga SL, Winters SJ. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertil Steril. 1994;61:598-604.
11. Hammoud A, Gibson M, Hunt SC, et al. Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. J Clin Endocrinol Metab. 2009;94:1329-1332.
12. Birkeland KI, Hanssen KF, Torjesen PA, Vaaler S. Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab. 1993;76:275-278.
13. Goodman-Gruen D, Barrett-Connor E. Sex hormone-binding globulin and glucose tolerance in postmenopausal women. The Rancho Bernardo Study. Diabetes Care. 1997;20:645-649.
14. Laaksonen DE, Niskanen L, Punnonen K, et al. Sex hormones, inflammation and the metabolic syndrome:Apopulation-based study. Eur J Endocrinol. 2003;149:601-608.
15. Brand JS, van der Tweel I, Grobbee DE, Emmelot-Vonk MH, van der Schouw YT. Testosterone, sex hormone-binding globulin and the metabolic syndrome: A systematic review and meta-analysis of observational studies. Intl J Epidemiol. 2011;40:189-207.
16. Veltman-Verhulst SM, van Haeften TW, Eijkemans MJ, de Valk HW, Fauser BC, Goverde AJ. Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome. Hum Reprod. 2010;25:3123-3128.
17. Ding EL, Song Y, Manson JE, et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009;361:1152-1163.
18. Haffner SM, Laakso M, Miettinen H, Mykkänen L, Karhapää P, Rainwater DL. Low levels of sex hormone-binding globulin and testosterone are associated with smaller, denser low density lipoprotein in normoglycemic men. J Clin Endocrinol Metab. 1996;81:3697-3701.
19. Lindstedt G, Lundberg PA, Lapidus L, Lundgren H, Bengtsson C, Björntorp P. Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes. 1991;40:123-128.
20. Calderon-Margalit R, Schwartz SM, Wellons MF, et al. Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: The "Coronary Artery Risk Development in Young Adults" women's study. J Clin Endocrinol Metab. 2010;95:4424-4431.
21. Gascón F, Valle M, Martos R, Ruz FJ, Ríos R, Montilla P, Cañete R. Sex hormone-binding globulin as a marker for hyperinsulinemia and/or insulin resistance in obese children. Eur J Endocrinol. 2000;143:85-89.
22. Perry JR, Weedon MN, Langenberg C, et al. Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Hum Mol Genet. 2010;19:535-544.
23. Le TN, Nestler JE, Strauss JF, 3rd, Wickham EP. 3rd 2012 Sex hormone-binding globulin and type 2 diabetes mellitus. Trends Endocrinol Metab. 2012;23:32-40.
24. Pugeat M, Crave JC, Elmidani M, et al. Pathophysiology of sex hormone binding globulin (SHBG): Relation to insulin. J Steroid Biochem Molec Biol. 1991;40:841-849.
25. Galloway PJ, Donaldson MD, Wallace AM. Sex hormone binding globulin concentration as a prepubertal marker for hyperinsulinaemia in obesity. Arch Dis Child. 2001;85:489-491.
26. Toscano V, Balducci R, Bianchi P, Guglielmi R, Mangiantini A, Sciarra F. Steroidal and non-steroidal factors in plasma sex hormone binding globulin regulation. J Steroid Biochem Molec Biol. 1992;43:431-437.
27. Katsuki A, Sumida Y, Murashima S, et al. Acute and chronic regulation of serum sex hormone-binding globulin levels by plasma insulin concentrations in male noninsulin-dependent diabetes mellitus patients. J Clin Endocrinol Metab. 1996;81:2515-2519.
28. Pasquali R, Vicennati V, Scopinaro N, et al. Achievement of near-normal body weight as the prerequisite to normalize sex hormone binding globulin concentrations in massively obese men. Int J Obes Relat Metab Disord. 1997;21:1-5.
29. Nestler JE, Powers LP, Matt DW, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinoland Metab. 1991;72:83-89.
30. Nestler JE, Barlascini CO, Matt DW, et al. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1989;68:1027-1032.
31. Pasquali R, Casimirri F, De Iasio R, et al. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. J Clin Endocrinol Metab. 1995;80:654-658.
32. Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab. 1988;67:460-464.
33. Loukovaara M, Carson M, Adlercreutz H. Regulation of production and secretion of sex hormone-binding globulin in HepG2 cell cultures by hormones and growth factors. J Ciin Endocrinol Metab. 1995;80:160-164.
34. Selva DM, Hogeveen KN, Innis SM, Hammond GL. Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. J Clin Invest. 2007;117:3979-3987.
35. Selva DM, Hammond GL. Peroxisome-proliferator receptor gamma represses hepatic sex hormone-binding globulin expression. Endocrinology. 2009;150(5):2183-189.
36. Danielson KK, Drum ML, Lipton RB. Sex hormone-binding globulin and testosterone in individuals with childhood diabetes. Diabetes Care. 2008;31:1207-1213.
37. Kapoor D, Channer KS, Jones TH. Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetes. Diab Vasc Dis Res. 2008;5:135-137.
38. Shin JY, Kim SK, Lee MY, et al. Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes. Diabetes Res Clin Pract. 2011;94:156-162.
39. Flechtner-Mors M, Schick A, Oeztuerk S, et al. 2013 Associations of fatty liver disease and other factors affecting serum SHBG concentrations: A population based study on 1657 subjects. Horm Metabolic Res. 2014;46:287-293.
40. Peter A, Kantartzis K, Machann J, et al. Relationships of circulating sex hormone-binding globulin with metabolic traits in humans. Diabetes. 2010;59:3167-3173.
41. Rhee J, Ge H, Yang W, et al. Partnership of PGC-1alpha and HNF4alpha in the regulation of lipoprotein metabolism. J Biol Chem. 2006;281:14683-14690.
42. Jänne M, Hammond GL. Hepatocyte nuclear factor-4 controls transcription from a TATA-less human sex hormone-binding globulin gene promoter. J Biol Chem. 1998;273:34105-34114.
43. Simó R, Barbosa-Desongles A, Lecube A, Hernandez C, Selva DM. Potential role of tumor necrosis factor-α in downregulating sex hormone-binding globulin. Diabetes. 2012;61:372-382.
44. Simó R, Barbosa-Desongles A, Hernandez C, Selva DM. IL1β down-regulation of sex hormone-binding globulin production by decreasing HNF-4α via MEK-1/2 and JNK MAPK pathways. Mol Endocrinol. 2012;26:1917-1927.
45. Simó R, Barbosa-Desongles A, Sáez-Lopez C, Lecube A, Hernandez C, Selva DM. Molecular mechanism of TNFalpha-induced downregulation of SHBG expression. Mol Endocrinol. 2012;26:438-446.
46. Moore JP, Jr, Winters SJ. Weaning and the developmental changes in follicle-stimulating hormone, pituitary adenylate cyclase-activating polypeptide, and inhibin B in the male rat. Biol Reprod. 2008;78:752-760.
47. Pugeat M, Nader N, Hogeveen K, Raverot G, Déchaud H, Grenot C. Sex hormone-binding globulin gene expression in the liver: Drugs and the metabolic syndrome. Mol Cell Endocrinol. 2010;316:53-59.
48. Tardivel-Lacombe J, Degrelle H. Hormone-associated variation of the glycan microheterogeneity pattern of human sex steroid-binding protein (hSBP). J steroid Biochem Molec Biol. 1991;39:449-453.
49. Cousin P, Déchaud H, Grenot C, Lejeune H, Hammond GL, Pugeat M. Influence of glycosylation on the clearance of recombinant human sex hormone-binding globulin from rabbit blood. J Steroid Biochem Molec Biol. 1999;70:115-121.
50. Jasuja GK, Travison TG, Davda M, et al. Age trends in estradiol and estrone levels measured using liquid chromatography tandem mass spectrometry in community-dwelling men of the Framingham Heart Study. J Gerontol A Biol Sci Med Sci. 2013;68:733-740.
51. Winters SJ, Atkinson L. Serum LH concentrations in hypogonadal men during transdermal testosterone replacement through scrotal skin: Further evidence that ageing enhances testosterone negative feedback. The Testoderm Study Group. Clin Endocrinol. 1997;47:317-322.
52. Nader N, Raverot G, Emptoz-Bonneton A, et al. Mitotane has an estrogenic effect on sex hormone-binding globulin and corticosteroid-binding globulin in humans. J Clin Endocrinol Metab. 2006;91:2165-2170.
53. Edmunds SE, Stubbs AP, Santos AA, Wilkinson ML. Estrogen and androgen regulation of sex hormone binding globulin secretion by a human liver cell line. J Steroid Biochem Molec Biol. 1990;37:733-739.
54. Bruning PF, Bonfrer JM, Hart AA, et al. Tamoxifen, serum lipoproteins and cardiovascular risk. Br J Cancer. 1988;58:497-499.
55. Mercier-Bodard Christine, Nivet V, Baulier EE. Effects of hormones on SBP mRNA levels in human cancer cells. J steroid Biochem. 1991;40:777-785.
56. Birzniece V, Sutanto S, Ho KK. Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators. J Clin Endocrinol Metabol. 2012;97:E521-E527.
57. Kottler ML, Dang CD, Salmon R, Counis R, Degrelle H. Effect of testosterone on regulation of the level of sex steroid-binding protein mRNA in monkey (Macaca fascicularis) liver. J Mol Endocrinol. 1990;5:253-257.
58. Watt AJ, Garrison WD, Duncan SA. HNF4: A central regulator of hepatocyte differentiation and function. Hepatol. 2003;37:1249-1253.
59. Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol. 2001;21:1393-1403.
60. Weissglas-Volkov D, Huertas-Vazquez A, Suviolahti E, et al. Common hepatic nuclear factor-4alpha variants are associated with high serum lipid levels and the metabolic syndrome. Diabetes. 2006;55:1970-1977.
61. Xie X, Liao H, Dang H, et al. Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs. Mol Endocrinol. 2009;23:434-443.
62. Saif-Ali R, Harun R, Kamaruddin NA, Al-Jassabi S, Ngah WZ. Association of hepatocyte nuclear factor 4 alpha polymorphisms with type 2 diabetes with or without metabolic syndrome in Malaysia. Biochem Genet. 2012;50:298-308.
63. Ahmed MH BC. 2011. Non-alcoholic fatty liver disease. In: Byrne CD WS, ed. The Metabolic Syndrome 2nd ed. Chichester, UK: Wiley-Blackwell; 245-277.
64. Polyzos SA, Kountouras J, Tsatsoulis A, et al. Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease. Hormones (Athens). 2013;12:405-416.
65. Jones H, Sprung VS, Pugh CJ, et al. Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance. J Clin Endocrin Metab. 2012;97:3709-3716.
66. Stefan N, Schick F, Haring HU. Sex hormone-binding globulin and risk of type 2 diabetes. New Engl J Med. 2009;361:2675-2676; author reply 2677-2678.
67. Bonnet F, Velayoudom Cephise FL, Gautier A, et al. Role of sex steroids, intrahepatic fat and liver enzymes in the association between SHBG and metabolic features. Clin Endocrinol. 2013;79:517-522.
68. Krishnasamy SS, Chang C, Wang C, Chandiramani R, Winters SJ. Sex Hormone-Binding Globulin and the risk for Metabolic Syndrome in Children of South Asian Origin. Endocr Pract. 2012;1-23.
69. Agirbasli M, Agaoglu NB, Orak N, et al. Sex hormones and metabolic syndrome in children and adolescents. Metabolism. 2009;58:1256-1262.